Calgary, Alberta (ots/PRNewswire) - TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix") announced today that it has closed a license agreement and formally entered into a definitive stock purchase agreement with Shenzhen Hepalink Pharmaceutical Co., Ltd. ("Hepalink"). The closing of the stock purchase ...
Teva Pharmaceutical Industries Ltd.
Amsterdam (ots/PRNewswire) - Teva Pharmaceutical Industries Ltd. today announced that its DuoResp Spiromax(R) inhaler has won silver at the 2015 Medical Design Excellence Awards (MDEA). The awards recognize significant advances in medical product design that improve the quality of healthcare delivery. DuoResp Spiromax(R) (budesonide/formoterol fumarate dihydrate) is a ...
Nuremberg, Germany (ots/PRNewswire) - - Internationally, only 16 percent of people are completely satisfied with the amount of leisure time they have. - America, Canada and UK have highest percentage of people who are satisfied; Russia and Japan have highest percentage dissatisfied. The busy pace of life is a popular complaint for many people. But findings released by ...
Lyon, France (ots/PRNewswire) - MSD, known as Merck in the United States and Canada and Sanofi Pasteur, the vaccines division of Sanofi , the two partner companies in Sanofi Pasteur MSD, announce today the appointment of David Khougazian as president of Sanofi Pasteur MSD. To view the Multimedia News Release, please click: ...
Bagsværd, Denmark (ots/PRNewswire) - Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the expanded use of Levemir(R) (insulin detemir) in children with diabetes as young as one year old. (Logo: http://photos.prnewswire.com/prnh/20141103/713759 ) There are an estimated 497,100 children living ...
Tokyo (ots/PRNewswire) - Press release not intended for US and UK media - EU approval paves the way for LIXIANA(R) (edoxaban) to be made available across all European member states - Marketing authorisation is based on data from the ENGAGE AF-TIMI 48 and Hokusai-VTE studies, the largest single comparative global ...
Toronto (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Today, at the International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress, Novo Nordisk announced the latest interim data from the guardian(TM)2 extension ...
Milan (ots/PRNewswire) - The new generation of subcutaneous defibrillators selected as most innovative in the field of cardiac electrophysiology. Attendees of EHRA EUROPACE-CARDIOSTIM 2015, a global medical conference held recently in Milan, Italy, have selected the EMBLEM(TM) S-ICD System as the most innovative ...
Calgary, Alberta (ots/PRNewswire) - TSX Exchange Symbol: RVX Resverlogix Corp. today announced that following recent meetings with various European regulatory bodies, the first confirmation for our Phase 3 clinical plan has officially been received. A further regulatory and protocol design update will be provided to the market post the approval of additional regulatory ...
Milan (ots/PRNewswire) - Scientific evidence and nutritional advice for a better life At EXPOMilano2015, food and nutrition was discussed during the international meeting "Back to Basics" which was attended by doctors, scientists and senior figures from around the world. Attendees included the Australian Robert Gibson, the Italian Carlo La Vecchia, Briton Sumantra Ray, the South African Christine Venter, the Swiss Luc ...
Tokyo (ots/PRNewswire) - Daiichi Sankyo announces the initiation of Hokusai-VTE Cancer, a multinational study investigating edoxaban in venous thromboembolism (VTE) associated with cancer Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the initiation of Hokusai-VTE Cancer, a multinational ...
Lyon, France (ots/PRNewswire) - The European Commission grants marketing authorization for GARDASIL 9, the only 9-valent HPV vaccine Sanofi Pasteur MSD announced today that the European Commission has granted marketing authorization for GARDASIL 9. GARDASIL 9 is a 9-valent HPV vaccine for active immunization of females and males from the age of 9 years against ...
Lausanne, Switzerland (ots/PRNewswire) - - Applicable to a wide variety of sample types to isolate bacteria, viruses, tumor cells, etc. - FibroTrap improves sensitivity and shortens time taken from sample collection to results - Spinomix to focus on the development of its flagship MagPhase technology Debiopharm ...
Chertsey, England (ots/PRNewswire) - - Results from Phase 1/2 trial investigating drug candidate for rare, aggressive blood cancer announced at European Hematology Association Congress; Phase 3 trial planned for late 2015 Astellas Pharma Europe today announced that preliminary data from a Phase 1/2 trial[a] on the ...
London (ots/PRNewswire) - World Leader In Medical Technology Adopts Field Service Management To Standardise Processes, Drive Efficiency Gains, and Better Organise Global Service Operations ServiceMax [http://www.servicemax.com ], the field service management solution for a new era of business, today announced that it has been selected by IBA (Ion Beam Applications S.A ...
Nuremberg, Germany (ots/PRNewswire) - - Over four out of 10 physicians and six out of 10 patients are not satisfied with the level of control achieved for moderate to severe adult patients treated with high potency topical steroids. - 91 percent of moderate to severe adults receiving high potency topical steroids ...
Montreal (ots/PRNewswire) - - New company DalCor to sponsor global phase III clinical trial to be led by MHI DalCor Pharmaceuticals Canada Inc. (DalCor) and the Montreal Heart Institute (MHI) announced today a collaboration in principle to conduct an international Phase III clinical trial which could result in a ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for US based media - Global Fertility Alliance will identify and work on improvements of fertility-related laboratory processes Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, today ...
Boston (ots/PRNewswire) - - 166-OR This material is intended for medical non-UK media only. For journalistic assessment and preparation before publication. New phase 3b findings showed adults with type 2 diabetes treated with Xultophy(R) (IDegLira), a once-daily, single-injection combination of insulin degludec and ...
Boston, Massachusetts (ots/PRNewswire) - This material is intended for medical non-UK media only. For journalistic assessment and preparation before publication Abstract #1121-P New findings showed that adults with type 2 diabetes treated with Victoza(R) , in combination with metformin, experienced similar ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - For Release in Europe Only - Resolor was approved in 2009 in Europe for use in women for the symptomatic treatment of chronic constipation in whom laxatives fail to provide adequate relief[1] Shire plc announced today that Resolor (prucalopride) has been approved by the European ...
Brussels (ots/PRNewswire) - Report[1] recommendations aim to improve management of AF as numbers expected to double from 8.8 to 17.9 million adults aged over 55 years between 2010 and 2060[2] Launched in Brussels today at the start of Heart Rhythm Week (1-7 June 2015) the Future of Anticoagulation Report[1] ...
Calgary, Alberta (ots/PRNewswire) - RVX-208, the first selective bromodomain extra-terminal (BET) protein inhibitor, significantly reduces alkaline phosphatase (ALP) levels in patients with high vascular risk Resverlogix Corp. (the "Company") today announced that new data on RVX-208 was presented at the ERA-EDTA ...
Darmstadt, Germany (ots/PRNewswire) - - Global collaboration to extend the portfolio of Merck Serono, a leading company in fertility treatment, in the growing market of fertility technologies to support standardization and improve fertility outcomes - Merck receives global marketing and commercialization rights for ...
London (ots/PRNewswire) - ViiV Healthcare, Aurobindo Pharma, and the Clinton Health Access Initiative, Inc. (CHAI) announced today that Aurobindo Pharma has submitted an Abbreviated New Drug Application (ANDA) for dolutegravir 50mg, for Tentative Approval, to the Food and Drug Administration (FDA), for the treatment ...
Darmstadt, Germany (ots/PRNewswire) - - Hypothyroidism is a disease affecting millions which often goes unrecognized - Symptoms of hypothyroidism often mistaken for other diseases Merck Serono, the biopharmaceutical business of Merck, today announced the support of 7th International Thyroid Awareness Week (ITAW). This year's campaign launched today for ITAW is aimed at ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK based media CHMP recommendation based on results from the Phase IIIb SPARK study Merck Serono, the biopharmaceutical business of Merck, today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued ...
Darmstadt, Germany (ots/PRNewswire) - - NOT INTENDED FOR US AND UK BASED MEDIA - ASCO Abstract # Avelumab*: 3023, 3044, 3055, TPS9086, TPS3101, 4042, 4047, 5509, 8034; evofosfamide: TPS9089, 8579; tepotinib: 2591; tecemotide[*]: 3036. - New data on priority candidates from Merck's oncology and immuno-oncology ...
London (ots/PRNewswire) - Bryan, Garnier & Co, the pan-European investment bank for growth companies, announces the successful $275 million Nasdaq IPO for Galapagos NV, a major European clinical-stage biotechnology company. Bryan, Garnier & Co is the only European investment bank in the IPO syndicate. The Galapagos ...
Darmstadt, Germany (ots/PRNewswire) - - NOT INTENDED FOR US AND UK BASED MEDIA - - Evofosfamide is an investigational compound currently in Phase III trials - Advanced pancreatic cancer is second indication to receive FDA fast track designation for evofosfamide Merck, a leading company for innovative and top-quality ...